Review
doi: 10.1016/s0958-1669(00)00153-1.
VEGF: an update on biological and therapeutic aspects
Affiliations
- PMID: 11102799
- DOI: 10.1016/s0958-1669(00)00153-1
Item in Clipboard
Review
VEGF: an update on biological and therapeutic aspects
Curr Opin Biotechnol.
2000 Dec.
Abstract
Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen and an angiogenic inducer as well as a mediator of vascular permeability. VEGF is essential for developmental angiogenesis and is also required for female reproductive functions and endochondral bone formation. Substantial evidence also implicates VEGF in tumors and intraocular neovascular syndromes. Currently, several clinical trials are ongoing to test the hypothesis that the inhibition of VEGF activity may be beneficial for these conditions.
Similar articles
-
The role of vascular endothelial growth factor in angiogenesis.Acta Haematol. 2001;106(4):148-56. doi: 10.1159/000046610. Acta Haematol. 2001. PMID: 11815711 Review.
-
Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.Semin Oncol. 2002 Dec;29(6 Suppl 16):10-4. doi: 10.1053/sonc.2002.37264. Semin Oncol. 2002. PMID: 12516033 Review.
-
Divergence of angiogenic and vascular permeability signaling by VEGF: inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability.Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):901-6. doi: 10.1161/01.atv.0000020006.89055.11. Arterioscler Thromb Vasc Biol. 2002. PMID: 12067896
-
Role of vascular endothelial growth factor in the regulation of angiogenesis.Kidney Int. 1999 Sep;56(3):794-814. doi: 10.1046/j.1523-1755.1999.00610.x. Kidney Int. 1999. PMID: 10469350 Review.
-
Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. doi: 10.2174/1568011033353452. Curr Med Chem Anticancer Agents. 2003. PMID: 12678905 Review.
Cited by
-
Inhibitory effects of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344 Rats: animal model of VEGF-targeted therapy for human endocrine tumors.Acta Histochem Cytochem. 2010 May 1;43(2):33-44. doi: 10.1267/ahc.09034. Epub 2010 Apr 7. Acta Histochem Cytochem. 2010. PMID: 20514290 Free PMC article.
-
Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis.J Clin Invest. 2004 Feb;113(4):516-27. doi: 10.1172/JCI18420. J Clin Invest. 2004. PMID: 14966561 Free PMC article.
-
Cross-Communication Between Knee Osteoarthritis and Fibrosis: Molecular Pathways and Key Molecules.Open Access J Sports Med. 2022 Mar 1;13:1-15. doi: 10.2147/OAJSM.S321139. eCollection 2022. Open Access J Sports Med. 2022. PMID: 35261547 Free PMC article. Review.
-
Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors.J Clin Oncol. 2010 Jan 10;28(2):207-14. doi: 10.1200/JCO.2009.22.9237. Epub 2009 Nov 30. J Clin Oncol. 2010. PMID: 19949018 Free PMC article. Clinical Trial.
-
Modulation of Apoptotic, Cell Cycle, DNA Repair, and Senescence Pathways by Marine Algae Peptides in Cancer Therapy.Mar Drugs. 2024 Jul 25;22(8):338. doi: 10.3390/md22080338. Mar Drugs. 2024. PMID: 39195454 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
